復星醫藥(600196.SH):擬申請公開發行不超80億元公司債券
格隆匯4月7日丨復星醫藥(600196.SH)公佈,為了進一步優化資產負債結構、拓寬融資渠道,滿足資金需求,公司擬申請公開發行公司債券,此次債券規模不超過人民幣80億元(含80億元)且應符合公司債券發行的相關規定。
此次債券將選擇向合格投資者公開發行的方式,在獲得證券交易所審核同意並經中國證券監督管理委員會註冊後可以一次或分期發行。具體發行規模及發行方式提請股東大會授權董事會(或其轉授權人士)根據相關法律法規及監管機構的意見和建議、公司資金需求情況和發行時市場情況,從維護公司利益的原則出發在前述範圍內全權確定。
此次債券的期限不超過7年(含7年),可以為單一期限品種,也可以為多種期限的混合品種。具體期限構成和各期限品種的規模提請股東大會授權董事會(或其轉授權人士)根據相關規定及發行時的市場情況確定。
此次債券的募集資金在扣除發行費用後,將用於補充集團營運資金和償還計息債務本息等用途。具體用途提請股東大會授權董事會(或其轉授權人士)根據公司財務狀況與資金需求情況,在上述範圍內確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.